LNTH
Lantheus Holdings, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Last price
99.97
▼ 0.27 (0.27%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
100.24
Prev close
100.24
Day high
100.46
Day low
99.97
Volume
1.07M
Market cap
$6.53B
P/E (TTM)
23.92
52W range
49.67 – 111.86
Day trading desk
Gap from prior close
+0.00%
Prior close 100.24
VWAP
100.15
-0.18% from price
Relative volume
0.59×
Quiet session
Session range
0.61%
99.85 – 100.46
Position in range
20%
Near session low
ATR (14D)
0.51
0.51% of price
Prior day high
100.69
PDH
Prior day low
100.06
PDL
Bid / ask spread
—
Quote not published
Session volume
792.42K
Avg 1.35M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.97%
+0.4%
1M
-3.62%
-7.4%
3M
+5.82%
+2.7%
6M
+35.33%
+24.3%
YTD
+50.22%
+37.9%
1Y
+78.07%
+58.1%
3Y
+49.81%
-24.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LNTH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.36M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 14, 26 | MAEUSLI HEINZ CHRISTOPH Director |
STOCK | 4.14K | $0 | Direct |
| May 14, 26 | MORROW PHUONG KHANH Director |
STOCK | 4.14K | $0 | Direct |
| May 14, 26 | MCHUGH JULIE H Director |
STOCK | 4.14K | $0 | Direct |
| May 14, 26 | EASTLAND JULIA MARIE Director |
STOCK | 4.14K | $0 | Direct |
| May 14, 26 | PRUDEN GARY J Director |
STOCK | 4.14K | $0 | Direct |
| May 14, 26 | BER GERARD Director |
STOCK | 4.14K | $0 | Direct |
| May 14, 26 | BAYLOR-HENRY MINNIE Director |
STOCK | 4.14K | $0 | Direct |
| May 14, 26 | LENO SAMUEL R Director |
STOCK | 4.14K | $0 | Direct |
| May 14, 26 | THRALL JAMES H Director |
STOCK | 4.14K | $0 | Direct |
| Mar 5, 26 | MARSHALL ROBERT J. JR. Chief Financial Officer |
STOCK | 38.00K | $0 | Direct |
| Mar 5, 26 | NIEDZWIECKI DANIEL M. General Counsel |
STOCK | 36.69K | $0 | Direct |
| Mar 5, 26 | MORGAN AMANDA MICHELLE Officer |
STOCK | 26.21K | $0 | Direct |
| Mar 5, 26 | BROWN KIMBERLY Officer |
STOCK | 6.16K | $0 | Direct |
| Mar 5, 26 | DINKELBORG LUDGER Officer |
STOCK | 20.97K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLANCHFIELD PAUL |
President | 108.21K | Sale |
DINKELBORG LUDGER |
Officer | 35.73K | Stock Award(Grant) |
FARALLON PARTNERS, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
HEINO MARY ANNE |
Chief Executive Officer | 589.20K | Stock Award(Grant) |
LENO SAMUEL R |
Director | 67.25K | Stock Award(Grant) |
MARKISON BRIAN A |
Chief Executive Officer | 232.42K | Stock Award(Grant) |
MARSHALL ROBERT J. JR. |
Chief Financial Officer | 122.79K | Stock Award(Grant) |
MORGAN AMANDA MICHELLE |
Officer | 64.15K | Stock Award(Grant) |
NIEDZWIECKI DANIEL M. |
General Counsel | 119.38K | Stock Award(Grant) |
THRALL JAMES H |
Director | 39.88K | Stock Award(Grant) |
Fundamentals
Market cap$6.53B
Enterprise value$6.56B
Revenue (TTM)$1.56B
Gross profit$936.02M
EBITDA$392.22M
Net income$275.30M
EPS (TTM)$4.18
Free cash flow$451.66M
Total cash$593.30M
Total debt$624.96M
Book value / share$20.10
Shares outstanding65.27M
Float58.50M
Short % of float12.85%
Dividend yield—
Beta (5Y)-0.03
Valuation & profitability ratios
Trailing P/E23.92
Forward P/E15.81
PEG ratio—
Price / sales—
Price / book4.97
EV / revenue4.21
EV / EBITDA16.72
Gross margin60.14%
Operating margin25.82%
Profit margin17.69%
Return on equity22.21%
Return on assets8.38%
Debt / equity47.64
Current ratio3.06
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.54B | $1.53B | $1.30B | $935.06M | +0.5% |
| Operating revenue | $1.54B | $1.53B | $1.30B | $935.06M | +0.5% |
| Cost of revenue | $599.66M | $545.62M | $586.89M | $353.36M | +9.9% |
| Gross profit | $941.95M | $988.29M | $709.54M | $581.70M | -4.7% |
| Research & development | $177.31M | $168.10M | $77.71M | $311.68M | +5.5% |
| Selling, general & admin | $453.81M | $371.63M | $267.19M | $233.83M | +22.1% |
| Total operating expense | $626.39M | $539.73M | $344.90M | $545.51M | +16.1% |
| Operating income | $315.56M | $448.56M | $364.64M | $36.20M | -29.7% |
| Net interest income | $3.64M | $17.17M | -$381.00K | -$4.57M | -78.8% |
| Pre-tax income | $313.79M | $430.98M | $410.94M | $26.72M | -27.2% |
| Tax provision | $80.23M | $118.53M | $84.28M | -$1.35M | -32.3% |
| Net income | $233.56M | $312.44M | $326.66M | $28.07M | -25.2% |
| Net income to common | $233.56M | $312.44M | $326.66M | $28.07M | -25.2% |
| Basic EPS | 3.46 | 4.52 | 4.79 | 0.41 | -23.5% |
| Diluted EPS | 3.41 | 4.36 | 4.65 | 0.40 | -21.8% |
| EBIT | $333.54M | $450.65M | $430.96M | $33.90M | -26.0% |
| EBITDA | $403.64M | $515.27M | $491.00M | $81.83M | -21.7% |
| Basic shares | 67.49M | 69.20M | 68.27M | 68.49M | -2.5% |
| Diluted shares | 68.44M | 71.65M | 70.24M | 70.67M | -4.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $359.12M | $912.81M | $713.66M | $415.65M | -60.7% |
| Cash & short-term investments | $359.12M | $912.81M | $713.66M | $415.65M | -60.7% |
| Accounts receivable | $358.64M | $321.26M | $284.29M | $213.40M | +11.6% |
| Inventory | $64.67M | $68.03M | $64.03M | $35.48M | -4.9% |
| Total current assets | $899.96M | $1.33B | $1.09B | $677.62M | -32.2% |
| Property, plant & equipment | $194.66M | $212.88M | $192.02M | $141.20M | -8.6% |
| Goodwill & intangibles | $962.30M | $222.95M | $213.17M | $376.47M | +331.6% |
| Total assets | $2.23B | $1.98B | $1.65B | $1.32B | +12.5% |
| Total current liabilities | $333.42M | $240.53M | $187.35M | $247.70M | +38.6% |
| Current debt | $738.00K | $974.00K | $823.00K | $354.00K | -24.2% |
| Long-term debt | $568.68M | $565.28M | $561.67M | $557.71M | +0.6% |
| Total debt | $619.43M | $619.44M | $616.95M | $583.51M | -0.0% |
| Total liabilities | $1.14B | $892.33M | $835.26M | $874.11M | +27.5% |
| Retained earnings | $679.50M | $445.94M | $133.50M | -$193.16M | +52.4% |
| Shareholder equity | $1.09B | $1.09B | $815.89M | $447.15M | +0.2% |
| Working capital | $566.54M | $1.09B | $898.47M | $429.92M | -47.8% |
| Net tangible assets | $127.50M | $865.06M | $602.72M | $70.67M | -85.3% |
| Shares issued | 71.83M | 70.91M | 69.86M | 68.85M | +1.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $233.56M | $312.44M | $326.66M | $28.07M | -25.2% |
| Depreciation & amortisation | $70.10M | $64.62M | $60.04M | $47.93M | +8.5% |
| Stock-based compensation | $85.56M | $76.39M | $50.51M | $29.26M | +12.0% |
| Change in working capital | -$44.23M | $2.05M | -$171.20M | -$75.06M | -2,259.9% |
| Operating cash flow | $390.14M | $544.75M | $305.26M | $281.78M | -28.4% |
| Capital expenditure | -$41.50M | -$79.63M | -$46.55M | -$18.35M | +47.9% |
| Investing cash flow | -$627.17M | -$226.01M | $5.94M | -$276.55M | -177.5% |
| Share buybacks | -$300.02M | -$100.00M | $0 | -$75.00M | -200.0% |
| Financing cash flow | -$316.58M | -$118.54M | -$13.06M | $311.69M | -167.1% |
| Free cash flow | $348.64M | $465.13M | $258.70M | $263.43M | -25.0% |
| End cash position | $360.83M | $914.49M | $715.28M | $417.24M | -60.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $388.18M | $377.33M | $406.79M | $384.01M | $378.05M | +2.9% |
| Operating revenue | $388.18M | $377.33M | $406.79M | $384.01M | $378.05M | +2.9% |
| Cost of revenue | $146.32M | $146.41M | $165.91M | $161.65M | $137.03M | -0.1% |
| Gross profit | $241.85M | $230.92M | $240.88M | $222.37M | $241.01M | +4.7% |
| Research & development | $38.20M | $39.38M | $47.48M | $48.02M | $45.49M | -3.0% |
| Selling, general & admin | $103.44M | $110.22M | $116.21M | $130.73M | $107.56M | -6.2% |
| Total operating expense | $141.64M | $149.60M | $163.69M | $178.75M | $153.04M | -5.3% |
| Operating income | $100.22M | $81.33M | $77.18M | $43.62M | $87.97M | +23.2% |
| Net interest income | $1.34M | $105.00K | -$2.00M | -$1.33M | $2.30M | +1,180.0% |
| Pre-tax income | $93.83M | $156.41M | $70.36M | $42.38M | $104.52M | -40.0% |
| Tax provision | $18.80M | $37.99M | $16.28M | $14.61M | $25.76M | -50.5% |
| Net income | $75.03M | $118.42M | $54.09M | $27.77M | $78.75M | -36.6% |
| Net income to common | $75.03M | $118.42M | $54.09M | $27.77M | $78.75M | -36.6% |
| Basic EPS | 1.15 | 1.83 | 0.82 | 0.41 | 1.15 | -37.2% |
| Diluted EPS | 1.11 | 1.80 | 0.82 | 0.41 | 1.12 | -38.3% |
| EBIT | $98.74M | $161.27M | $75.44M | $47.33M | $109.43M | -38.8% |
| EBITDA | $121.32M | $183.95M | $98.28M | $67.74M | $122.67M | -34.0% |
| Basic shares | 65.16M | 64.74M | 65.58M | 67.23M | 68.52M | +0.7% |
| Diluted shares | 67.52M | 65.77M | 66.31M | 67.66M | 70.31M | +2.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $593.30M | $498.58M | $359.12M | $382.01M | $695.57M | +19.0% |
| Cash & short-term investments | $593.30M | $498.58M | $359.12M | $382.01M | $695.57M | +19.0% |
| Accounts receivable | $352.89M | $355.67M | $358.64M | $351.38M | $336.58M | -0.8% |
| Inventory | $57.55M | $61.34M | $64.67M | $62.04M | $62.16M | -6.2% |
| Total current assets | $1.03B | $942.29M | $899.96M | $925.09M | $1.20B | +9.0% |
| Property, plant & equipment | $153.27M | $157.56M | $194.66M | $164.07M | $157.73M | -2.7% |
| Goodwill & intangibles | $928.38M | $945.46M | $962.30M | $979.59M | $536.82M | -1.8% |
| Total assets | $2.41B | $2.35B | $2.23B | $2.28B | $2.12B | +2.9% |
| Total current liabilities | $335.68M | $333.17M | $333.42M | $346.84M | $280.13M | +0.8% |
| Current debt | $697.00K | $803.00K | $738.00K | $871.00K | $796.00K | -13.2% |
| Long-term debt | $570.35M | $569.60M | $568.68M | $567.94M | $566.85M | +0.1% |
| Total debt | $624.96M | $625.75M | $619.43M | $619.44M | $615.49M | -0.1% |
| Total liabilities | $1.10B | $1.13B | $1.14B | $1.16B | $949.29M | -2.8% |
| Retained earnings | $872.95M | $797.92M | $679.50M | $625.42M | $597.64M | +9.4% |
| Shareholder equity | $1.31B | $1.21B | $1.09B | $1.12B | $1.17B | +8.2% |
| Working capital | $691.38M | $609.12M | $566.54M | $578.25M | $921.68M | +13.5% |
| Net tangible assets | $383.39M | $266.83M | $127.50M | $139.61M | $629.97M | +43.7% |
| Shares issued | 65.27M | 72.31M | 71.83M | 71.77M | 71.70M | -9.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $75.03M | $118.42M | $54.09M | $27.77M | $78.75M | -36.6% |
| Depreciation & amortisation | $22.58M | $22.68M | $22.83M | $20.41M | $13.23M | -0.4% |
| Stock-based compensation | $20.01M | $16.04M | $17.54M | $24.50M | $22.32M | +24.7% |
| Change in working capital | $11.07M | $22.83M | -$16.29M | $1.28M | -$10.93M | -51.5% |
| Operating cash flow | $92.20M | $125.13M | $90.18M | $105.29M | $87.11M | -26.3% |
| Capital expenditure | -$2.33M | -$3.23M | -$8.79M | -$10.62M | -$13.37M | +27.6% |
| Investing cash flow | -$2.02M | $25.99M | -$11.51M | -$319.47M | -$232.47M | -107.8% |
| Share buybacks | — | — | -$100.02M | -$100.00M | — | — |
| Financing cash flow | $4.50M | -$11.62M | -$100.79M | -$99.17M | -$98.41M | +138.8% |
| Free cash flow | $89.87M | $121.90M | $81.39M | $94.67M | $73.73M | -26.3% |
| End cash position | $595.01M | $500.29M | $360.83M | $383.70M | $697.26M | +18.9% |
Options analytics
Put / call volume
0.22
Call-heavy session
Put / call open interest
0.69
Positioning, not flow
Max pain
95.00
-5.0% from spot
ATM implied vol
19.0%
Nearest strike to spot
Skew (10% OTM)
+1.3%
Puts bid over calls
Call volume
50
Contracts, this expiry
Put volume
11
Contracts, this expiry
Heaviest call OI
105.00
95 contracts
Heaviest put OI
100.00
38 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.30 | 1.55 | +18.9% |
| Mar 2026 | 1.23 | 1.46 | +18.8% |
| Dec 2025 | 1.17 | 1.67 | +42.9% |
| Sep 2025 | 1.27 | 1.27 | +0.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.35 | 5 | $360.78M | -6.1% |
| Next quarter | 1.40 | 5 | $365.67M | -10.1% |
| Current year | 5.60 | 3 | $1.50B | -2.7% |
| Next year | 6.32 | 11 | $1.65B | +9.9% |
Analyst targets & ownership
Mean target$107.04
High target$115.00
Low target$102.50
Implied upside7.07%
Analyst count10
ConsensusHOLD
Strong buy / Buy1 / 2
Hold8
Sell / Strong sell0 / 0
Held by insiders2.08%
Held by institutions117.16%
Institutions holding606
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
100.61
-0.64% from price
SMA 20
101.16
-1.18% from price
SMA 50
103.98
-3.86% from price
SMA 100
96.70
+3.38% from price
SMA 200
81.86
+22.13% from price
EMA 12
100.77
-0.80% from price
EMA 26
101.67
-1.67% from price
EMA 50
101.13
-1.14% from price
RSI (14)
42.4
Neutral
MACD (12,26,9)
-0.90
Hist -0.04
ATR (14)
0.51
0.51% of price
Realised vol 30D
28.6%
Annualised
Bollinger upper
104.55
20, 2σ
Bollinger lower
97.78
20, 2σ
50 / 200 cross
Golden
103.98 vs 81.86
Trend bias
Above 200
+22.13%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.56
Less volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
28.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-15.3%
Peak to trough
Max drawdown 5Y
-59.5%
Peak to trough
ATR 14
0.51
0.51% of price
Beta (reported)
-0.03
5Y monthly, from filing
Short interest
Shares short
6.31M
Prior 6.33M
Change vs prior
-0.4%
Shorts covering
% of float
12.85%
Elevated
% of shares out
9.67%
Against total outstanding
Days to cover
7.0
Crowded exit
Float
58.50M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 4, 26 | Truist Securities | DOWNGRADE | Buy | Hold |
| Aug 4, 26 | CJS Securities | DOWNGRADE | Market Outperform | Market Perform |
| Aug 3, 26 | William Blair | DOWNGRADE | Outperform | Market Perform |
| Aug 3, 26 | TD Cowen | DOWNGRADE | Buy | Hold |
| Jul 29, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 16, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 15, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 9, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Jun 29, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| May 27, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| May 11, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| May 8, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
SEC filings
Proxy Statements
DEFA14A · 2026-08-13
Periodic Financial Reports
10-Q · 2026-08-06
Proxy Statements
DEFA14A · 2026-08-04
Proxy Statements
DEFA14A · 2026-08-03
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-01
Proxy Statements
DEF 14A · 2026-03-20
Headlines
Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH)
StockStory · 2d ago
B. Riley Downgrades Lantheus Holdings to Neutral From Buy, Cuts Price Target to $105.40 From $129 Amid Curium Deal
MT Newswires · 5d ago
Lantheus Wins FDA Approval for Alzheimer's Tau Imaging Agent Tauklarify
MT Newswires · 9d ago
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
GlobeNewswire · 9d ago
Lantheus' Q2 Adjusted Earnings Fall, Revenue Rises
MT Newswires · 17d ago
Lantheus Holdings: Q2 Earnings Snapshot
Associated Press · 17d ago
Lantheus (NASDAQ:LNTH) Reports Upbeat Q2 CY2026
StockStory · 17d ago
Lantheus Reports Second Quarter 2026 Financial Results
GlobeNewswire · 17d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.